Disclaimer Agreement

Disclaimer Notice

This legal notice governs your use of this website – www.amiowealth.com. This website is issued by Amio Wealth Limited (AMIO), a private limited company registered in England and Wales under number 10701266 and whose registered address is at 7 John Street, London, WC1N 2ES. Amio Wealth Limited (FCA Number: 779660) is an appointed representative of Consero Capital LLP (FCA Number: 570728) (CONSERO), which is authorised and regulated by the Financial Conduct Authority.

Any document or information appearing on this website or any of its pages or communication transmitted thereby (a Communication) does not constitute or form part of an offer to issue or sell or the solicitation of an offer to subscribe for or purchase any investment by anyone in any jurisdiction in which such offer or solicitation is not authorised or to anyone to whom it is unlawful to make such a solicitation nor does it constitute investment advice, but is provided for information purposes only and without regard to any particular person’s investment objectives, financial situation, or means. Neither any Communication, nor the fact of its distribution or transmission, form the basis of, nor may be relied on in connection with, any contract to subscribe for or purchase any investment.

Any Communication is being issued to and/or directed at persons who are personally categorising themselves either as a sophisticated investor and/or high net worth individual by completing the appropriate forms on this website, being only those persons to whom AMIO may lawfully promote and arrange investments on behalf of CONSERO. Any Communication is exempt from the scheme promotion restriction of section 238 of the Financial Services and Markets Act 2000 on the communication of invitations or inducements to participate in unrecognised collective investment schemes on the grounds that it is being issued to and/or directed at only those types of persons who are sophisticated investors and/or high net worth individuals. AMIO and CONSERO will be entitled to rely on any client categorisation you give and the information you give in connection therewith and shall have no liability to you if you provide inaccurate or misleading information for the purposes of determining that client categorisation.

You should read the offering documents of the investments in their entirety to which any Communication relates or comprises, and inform themselves of and observe all applicable laws and regulations, including any taxation or exchange control legislation, which may be relevant in connection with any investment before considering any such investment. The value of investments may go down as well as up and past performance is not necessarily a guide to future performance. Although AMIO has taken all reasonable care to ensure that the information contained within this document is accurate at the time of publication, no representation or warranty is made as to its accuracy, reliability or completeness. Information contained in any Communication may be subject to change and we cannot guarantee the validity of any statement or figure after the date of its publication.

Amio Wealth Limited is not authorised to give investment advice and as such you should consider seeking advice of an appropriately authorised or regulated financial advisor. The products and services available do not therefore offer recourse to the Financial Ombudsman Service or the Financial Services Compensation Scheme. 

The law of England and Wales governs access to and use of this website. By accessing this website, you acknowledge that you have read and understood the conditions of use, the privacy policy and have agreed to accept these conditions and you represent and warrant you satisfy any investor qualification tests required to be met by you in accessing the site or by any potential investment in any products on which information is provided.

This website is run by Amio Wealth Limited (We/Us) and we are committed to protecting and respecting your privacy.

This Privacy and Cookies Policy (this Policy) (together with our Disclaimer Agreement which contains terms of use of our website www.amiowealth.com and any other documents referred to on it) sets out the basis on which any personal data we collect from you, or that you provide to us, will be processed by us.  Please read the following carefully to understand our views and practices regarding your personal data (the Data) and how we will treat it. By visiting www.amiowealth.com (our website) you are accepting and consenting to the practices described in this Policy.

For the purpose of the Data Protection Act 1998 (the Act), we are the data controller and our registered address at 7 John Street, London, WC1N 2ES (ICO Registration Number ZA253142).

The nature of the restricted regulated services (the Services) as advertised to be provided by us on our website means that we might obtain certain Data about you. This statement sets out the principles governing our use of your Data (Use). By registering and using our website generally, you agree to this Use.


Privacy Policy & Cookies

1. Information we collect from you

We will collect and process the following Data about you:

Information you give us. This is information about you that you give us by filling in forms on our website or by corresponding with us by phone, e-mail or otherwise. It includes information you provide when you register to use our website, subscribe to our online service, search for an investment product and any other activities commonly carried out on our website. The information you give us may include your name, address, e-mail address and phone number and financial information indicative of your financial standing with respect to any proposed investment you may wish to make and that we have been requested to obtain on behalf of clients.

Information we collect about you. With regard to each of your visits to our website we may  collect the following information from time to time:

2. Cookies

Our website may use cookies to distinguish you from other users of our website. This helps us to provide you with a good experience when you browse our website and also allows us to improve our website. Please see below for an outline of the cookies we use on our website:

Type of Cookie Cookie Name Expires After Purpose
Site Performance
 180 days from set/update
Performance cookies collect anonymous information about how visitors use our site, for example how many visitors came to our site and when, what browsers visitors use and how long visitors stay on the site. This data does not contain any information that is personal to you.


Google Analytics: __utma 2 years from set/update
Google Analytics: __utmb 30 minutes from set/update
Google Analytics: __utmc not set
Google Analytics: __utmz
6 months from set/update

We cannot guarantee full operability of our website if you disable your cookies. For detailed information about cookies, please visit http://www.allaboutcookies.org/. 

By continuing to browse the site, you are agreeing to our use of cookies.


3. Uses made of the information

We will use this information:


4. Disclosure of your Data

For the avoidance of doubt, we will not disclose your Data to any third parties other than in accordance with this Policy and in the circumstances detailed below:


5. Where we store your personal data

We will take all steps reasonably necessary to ensure that your data is treated securely and in accordance with this Policy.

All information you provide to us is stored on our secure servers. Where we have given you (or where you have chosen) a password which enables you to access certain parts of our website, you are responsible for keeping this password confidential. We ask you not to share a password with anyone.


6. Your rights

You have the right to ask us not to process your personal data for marketing purposes. We will usually inform you (before collecting your data) if we intend to use your data for such purposes or if we intend to disclose your information to any third party for such purposes. You can exercise your right to prevent such processing by checking certain boxes on the forms we use to collect your data.  You can also exercise the right at any time by contacting us on +44 20 3307 1250 or at info@amiowealth.com.


7. Third Party Links

Our website may, from time to time, contain links to and from other websites. The fact that we have provided these third party links at our website does not constitute an endorsement, authorization, sponsorship or affiliation by us with respect to the third party’s website, its owners or its providers. If you follow a link to any of these websites, please note that these websites have their own privacy policies and that we do not accept any responsibility or liability for these policies.  Please check their policies before you submit any personal data to these websites.


8. Access to Data

In accordance with the Act you have the right to access any Data that we hold relating to you. Please note that we reserve the right to charge a fee of £10 to cover costs incurred by us in providing you with the information.


Contacting Us

Please do not hesitate to contact us regarding any matter relating to this Policy at Amio Wealth Limited, 3-6 Kenrick Place, London, W1U 6HD or info@amiowealth.com.

Amio Wealth Limited (FCA Number 779660) is an appointed representative of Consero Capital LLP (FCA Number: 570728), which is authorised and regulated by the Financial Conduct Authority.


Client Login

Soaring past the traditional: Where is the healthcare industry heading to?

October 26, 2017

Soaring past the traditional: Where is the healthcare industry heading to?

Soaring past the traditional: Where is the healthcare industry heading to?

The developments within the tech world has been most noticeable in our daily lives’ through the development of the communications system. Technological advances have benefited a cross range of sectors, in the healthcare sector this has been particularly focused on assisting a healthier, longer and positive lifestyle.

Room for Improvement

The healthcare industry has increased its performance over the last few years – from the successful introduction of stem cell research to achieving a deeper understanding of the significance of our chromosomes in each strand of our DNA. The understanding developed of the human organism and the variables which affect it have advanced the way we take care of our ourselves – internally and externally. Yet it seems that the government, particularly in the United Kingdom, is not placing sufficient efforts into supporting and implementing the advances which could be used by the NHS. This is particularly worrying due to the increase of pollution across the United Kingdom.

A report released last week by international experts, indicates that pollution has caused more deaths in the UK than in many other countries in western Europe, highlights the need for a technological boost is as important as ever. Pollution kills 9m people per year globally, this is specifically relevant in areas with increased and dense pollution. Although not to discourage environmental changes put forward by the government (e.g. London’s new T-Charge to lower congestion by implanting a new £21.50 daily charge to drive in central London), the adaptability that cities such as London could attain with the potential of investing into new technologies are immense.

Ceasing the moment

The NHS forms a core part of the British health system. Albeit its strengths, there is much scope for development. Private companies are currently taking advantage of the space left by underfunded public bodies especially when it concerns technological development. This is giving companies an opportunity to enter this space with providing the sector advances in technology.

In cosmetics and beauty, countries such as South Korea have led the way in beauty innovation making it a beauty powerhouse. Plastic surgery levels have soared in South Korea due to their affordability, which has been linked to the advances in technology this sector has recently seen. The UK has a strong export market with both the beauty and technology industries at the forefront of this important driver of income for the UK. The latter of these has recently seen a huge uplift which has contributed to a higher concentration of innovation to capitalise on this booming market.

The UK government is helping stimulate the market with incentives such as the Enterprise Investment Scheme (also known as “EIS”) which includes companies focused on technology. The benefit of technology companies being included in EIS’s has been highlighted by the chief of the Consumer Electronic Show (“CEIS”) who has heralded the success of the EIS incentive whilst emphasising its importance in bringing private investment to innovative sectors. In conjunction with financial aid given from the UK government, the CES is helping fund a selection of start-ups to attend its next event in January.

Some companies have made a key move forward. IDDNA’s (www.suisselifescience.com) impressive portfolio makes it one of the most interesting companies across Europe. By using Artificial Intelligence (“AI”) and science, they pinpoint the root of aging and develop a personalised plan built from your genetic information and surroundings. The treatments are biologically active, so no drugs are used. IDDNA’s revolutionary new technology is backed by significant individuals in the tech industry, who are in agreement that AI and “on-device computing” could make a significant difference in healthcare.

In conclusion, Europe and specifically the UK has developed the possibility of becoming a world-class market leader in technology who have been heavily vested in AI for the past decade. The revolution will not come in the shape of robots, but in a form suitable for all generations for a progressive future.

Elizabeth Frumson ® Amio Wealth Limited

All sources have been acknowledged.

Capital at Risk. No FSCS cover. See DISCLAIMER.